Tuesday, April 08, 2025 5:30:42 PM
BioClonetics Immunotherapeutics described its anti-HIV monoclonal antibody at the following link:
https://wefunder.com/bioclonetics/details (See the section entitled "Company Overview".)
When BioClonetics Immunotherapeutics merged with ENZC, I had the option of pulling my investment out. But I stayed invested because I believed in the monoclonal antibody and because I was led to believe that ENZC would continue the work on this antibody.
The Cotropias and Chandra took this antibody technology and abandoned ENZC, cheating investors who had invested into BioClonetics Immunotherapeutics and/or ENZC just because of the antibody technology.
Docsetc is trying to pressure the Cotropias and Chandra to give cheated investors some type of restitution, even if that pressuring involves making them think that there will be a lawsuit. Why are you sabotaging Docsetc in his efforts?
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
